OrganiGram (TSE:OGI) had its price target boosted by Jefferies Financial Group from C$3.48 to C$3.57 in a research report released on Thursday, Analyst Price Targets reports. Jefferies Financial Group also issued estimates for OrganiGram’s Q4 2021 earnings at $0.09 EPS.
Several other equities research analysts have also issued reports on OGI. Alliance Global Partners dropped their target price on shares of OrganiGram from C$4.00 to C$3.75 and set an underpeform rating for the company in a research report on Thursday, April 15th. Canaccord Genuity boosted their price objective on shares of OrganiGram from C$2.00 to C$3.50 and gave the stock an underperform rating in a report on Wednesday, April 14th. CIBC lowered shares of OrganiGram from a neutral rating to an underperform rating and lowered their price objective for the stock from C$5.00 to C$3.25 in a report on Wednesday, April 14th. Raymond James lowered their price objective on shares of OrganiGram from C$6.00 to C$5.00 and set an outperform rating for the company in a report on Tuesday, April 13th. Finally, Haywood Securities lowered their price objective on shares of OrganiGram from C$4.75 to C$3.50 and set an underperform rating for the company in a report on Wednesday, April 14th. Four equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of Hold and an average target price of C$3.78.
OrganiGram stock traded up C$0.09 during mid-day trading on Thursday, hitting C$3.23. 747,722 shares of the company traded hands, compared to its average volume of 4,557,149. OrganiGram has a one year low of C$1.35 and a one year high of C$8.00. The stock has a market cap of C$963.29 million and a price-to-earnings ratio of -2.81. The company has a debt-to-equity ratio of 23.71, a quick ratio of 4.11 and a current ratio of 6.66. The stock has a fifty day moving average price of C$4.15 and a 200-day moving average price of C$2.74.
Organigram Holdings Inc, through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co, ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market.
Featured Article: What is systematic risk?
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.